Press Release
LingSense Bio Debuts in Silicon Valley With Advanced CGM & Wearable Dynamic Blood Pressure Technology
While the global digital health industry remains focused on specification-driven competition and fragmented use cases, LingSense Bio, a rising Chinese medtech innovator, chose Silicon Valley as the stage to present its answer.
At the “BEYOND SLEEP: THE STAREEP PREMIERE” global launch event, LingSense Bio, official medical health partner of smart sleep brand Stareep, made its international debut, introducing a comprehensive, closed-loop health management solution that integrates hardware, software, and AI services. This innovation aims to redefine healthcare standards for billions of chronic disease patients worldwide.
LingSense Bio’s wearable product lineup made a stunning debut
The LingSense Bio Ecosystem Ushers in an All in One AI Era of Seamless Monitoring
With the global chronic disease management market expanding rapidly into a trillion-dollar industry, Faris Li, Head of Product at LingSense Bio, delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.” His assessment was direct: “Hardware alone cannot solve the challenges of chronic disease management. Without AI-driven intervention, health data is just a pile of numbers.”
Faris highlighted that while over 626 million people suffer from cardiovascular diseases and 830 million live with diabetes globally, continuous glucose monitoring (CGM) penetration among type 2 diabetes patients remains below 10%. Furthermore, dynamic blood pressure monitoring has long been constrained by traditional cuff-based devices. “Patients need unobtrusive, continuous, and precise monitoring, not fragmented occasional readings,” Faris emphasized. The future of medical-grade wearables, he noted, lies in two key trends: multi-parameter “All-in-One” integration and deep AI embedding from edge to platform.
To address these needs, LingSense Bio has developed a product matrix. Faris Li showcased two groundbreaking core hardware innovations:
Continuous Glucose Monitor (CGM): Boasting an industry-leading MARD (Mean Absolute Relative Difference) of under 8.0%, rivaling top-tier global brands.
Wearable dynamic Blood Pressure Monitor (dBP): The world’s first wearable dBP powered by Tonoarteriography (TAG) technology, developed by Professor Yuan-Ting Zhang’s team, delivering medical-grade continuous blood pressure tracking.
LingSense Bio also introduced LingWatch Pro, a smart watch with dynamic blood pressure monitoring; LingRing Nexus R1, a smart ring integrating non-invasive blood glucose trend monitoring, PPG, blood oxygen, temperature, and heart rate variability (HRV) monitoring; and LingCare SpringMini, a portable oxygen concentrator designed to provide stable oxygen supply at altitudes of up to 6,000 meters.
These devices function as specialized physiological sensors that stream data into the LingSense Chronic Disease Management Platform, forming a closed-loop ecosystem covering glucose, blood pressure, blood oxygen, and ECG.
Faris Li delivered a keynote speech titled “Redefining Health Monitoring with Healthcare AI Wearables.”
Professor Yuan-Ting Zhang: Three Decades of Cuffless Innovation Reach Industrial Standard Moment
At the event, Professor Yuan-Ting Zhang, a Fellow of the International Academy for Medical and Biological Engineering, delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.” With over 30 years of pioneering research in cuffless blood pressure monitoring, Academician Zhang shared clinical insights and engineering philosophies that underscore the team’s forward-looking approach to digital cardiovascular health.
Professor Zhang pointed out that traditional blood pressure monitoring fails to capture critical nocturnal data. Clinical follow-ups from the Dublin Hypertension Clinic show that nighttime hypertension is highly correlated with a 5-year risk of cardiovascular mortality, and increased blood pressure variability serves as an independent warning sign. “However, traditional cuff-based devices cannot frequently inflate while a patient is sleeping without disrupting their rest,” Professor Zhang noted, highlighting the necessity of cuffless wearable technology. The deep learning models developed by his team for systolic and diastolic measurements have already achieved Grade A performance under IEEE, AAMI, and BHS standards.
Professor Yuan-Ting Zhang delivered a presentation titled “AI-Empowered Tonoarteriography for Digital Cardiovascular Health.”
The “dBP” solution represents a new era of 24/7 health management. By fusing physiological sensing, intelligent algorithms, and continuous data analysis, it offers a natural, low-burden monitoring experience. “The dBP focuses on long-term health trends rather than isolated readings,” Professor Zhang explained. “By analyzing continuous data streams, the system can provide valuable clinical insights for diagnosing masked hypertension, nocturnal anomalies, and evaluating chronic disease risks.”
Notably, Daniel Franklin, an Assistant Professor in the Institute of Biomedical Engineering at the University of Toronto, traveled to Silicon Valley as a specially invited international guest for the event. He participated in a session themed “Technology & Healthy Sleep,” where he engaged in an in-depth academic dialogue with fellow attendees. Known for his work in bio-integrated electronics and soft-matter photonics, Franklin offered an independent, clinically informed perspective on the event’s most anticipated innovation, the wearable dynamic blood pressure (dBP) monitoring technology.
Daniel Franklin participated in a session themed “Technology & Healthy Sleep” and shared in-depth academic insights
Data from LingSense Bio’s wearable product matrix, including CGM readings, ambulatory blood pressure data, blood oxygen saturation, and ECG signals, will be synchronized in real time to the LingSense Chronic Disease Management Platform. Built on LingSense Bio’s self-developed, medical-grade AI large model, the platform analyzes continuous health data and identifies potential risk patterns. It further incorporates Dr. PAI (Personalized AI Doctor), the world’s first hypertension intelligent management platform that combines a wearable dynamic blood pressure monitoring device, an AI health assistant avatar, and a large language model, developed by the team led by Professor Zhang. Together, they deliver a closed-loop experience spanning AI-powered consultation, health assessment, blood pressure pattern recognition, and personalized health management recommendations.
In January 2026, the U.S. Food and Drug Administration (FDA) officially released the draft guidance titled “Cuffless Non-invasive Blood Pressure Measuring Devices – Clinical Performance Testing and Evaluation,” marking a long-awaited standard for the industrialization of a technology nearly three decades in the making. Professor Zhang’s team has been deeply involved in the development of both the FDA draft guidance and the relevant IEEE standard; the IEEE standard led by his team has already been adopted by the FDA as a reference. “The world is embracing this standard, and LingSense is ready to be tested,” Professor Zhang said.
A China-Born Solution for Global Standards
As the Silicon Valley sun cast its glow over Stanford, LingSense Bio’s brand logo lit up across the giant screen. Without complicated regulatory language or excessive marketing rhetoric, LingSense had already delivered its message: connecting China’s precision with the world’s broader healthcare needs.
From CGM systems with an MARD below 8.0% to the medical-grade continuous wearable blood pressure monitor dBP, LingSense Bio is challenging a market long dominated by industry giants like Dexcom and Abbott. But for chronic disease patients around the world, the most meaningful takeaway from this launch may be what LingSense Bio President Zhifeng Peng put most simply: “Whether you live in a major city or a remote village, expert-level personal healthcare should not be a privilege.” This China-born solution, making its debut in Silicon Valley, is now accelerating onto the global stage.
Media Contact
Organization: LingSense Bio (Shenzhen) Technology Co., Ltd.
Contact Person: Ying Jixuan (Nancy)
Website: https://en.lingshee.com
Email:
yingjixuan@dreame.tech
City: Shanghai
Country:China
Release id:45276
The post LingSense Bio Debuts in Silicon Valley With Advanced CGM & Wearable Dynamic Blood Pressure Technology appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials
This Enterprise Unveils Industrial High-Purity Lipid Raw Material Product Portfolio for Global Fine Chemical Clients
Guangzhou, Guangdong, China, 21st May 2026 – Guangzhou Hanfang Pharmaceutical Company Limited. (a subsidiary of Guangzhou Pharmaceutical Holdings Limited) today announced updates to its industrial lipid raw material product portfolio and global service upgrades. The company’s offerings include industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), tailored to meet industrial production requirements across multiple regions. Adopting a comprehensive business model encompassing direct sales, distribution, custom processing, and technical support, the enterprise serves over 1,000 clients worldwide with a business network spanning more than 20 countries and regions, further expanding its global fine chemical supply chain footprint.
Core Product Portfolio and Technical Services
Guangzhou Baiyunshan Hanfang Pharmaceutical provides products and services tailored for industrial fine chemical enterprises and related industries:
- Industrial High-Purity Lipid Raw Materials: Supplies industrial high-purity egg yolk lecithin, medium-chain triglycerides, and soybean oil (general-purpose raw material), serving as core components for emulsifiers, cosolvents, and industrial energy additive raw materials, complying with process standards for industrial production scenarios.
- Customization and Technical Support: Delivers customized solutions for exclusive raw material formulation needs, including compliant adjustments to component ratios and performance parameters; the technical team provides end-to-end guidance on production process applications.
- Comprehensive Business Model: Covers direct sales, authorized distribution, custom processing, and technical services, meeting diverse needs from standard orders to customized projects.
Global Compliance and Quality Standards
The enterprise has established operational and quality systems aligned with international fine chemical supply chain norms. Its production base in Conghua, Guangzhou, adopts fully controlled end-to-end processes to ensure consistent product quality. Products are sold across Asia, Europe, and other regions, with efficient delivery enabled by mature logistics channels.
Supply and Service Information
Products are available globally through the direct sales team and authorized distributors. Orders are accepted from industrial fine chemical enterprises and related manufacturers, with standard production lead times provided. Custom processing services are available for premium clients, alongside formulation technical consultations. Clients may inquire via the official website or regional sales representatives.
“We focus on ensuring the stability of the fine chemical supply chain, with deep expertise in the lipid raw material sector,” said Chen Shiqi, Project Manager at Guangzhou Baiyunshan Hanfang Pharmaceutical. “We are committed to delivering stable, reliable products and technical support to meet the evolving needs of our global clients.”
Industry Background and Strategic Direction
Industry data indicates sustained growth in global demand for high-quality industrial lipid raw materials, driven primarily by the expansion of global fine chemical production capacity and the need for supply chain resilience. As a member enterprise of Guangzhou Pharmaceutical Holdings Limited, Baiyunshan Hanfang closely follows trends in the fine chemical supply chain industry, focusing on product stability and global technical services to support the growth of clients worldwide.
Future Plans
Guangzhou Baiyunshan Hanfang Pharmaceutical will continue to increase investment in production capacity and product R&D, with plans to expand its global distribution network, upgrade technical service systems for international clients, and prioritize meeting the diverse production needs of core markets.
About Guangzhou Hanfang Pharmaceutical Company Limited
Founded in 1998 and headquartered in Guangzhou, Guangzhou Hanfang Pharmaceutical Company Limited employs more than 330 people across production, R&D, quality control, and administration. The enterprise specializes in industrial fine chemical raw materials, lipid raw materials, and supporting technical services, with products sold in over 20 countries and regions. It holds multiple patents for lipid processing technologies, with its Conghua production base serving as the core production hub. The enterprise’s mission is “stable supply, technical collaboration, empowering the global fine chemical industry.”
For more information, please visit the official website: https://www.byshanhanfang.com/
Media Contact
Organization: Guangzhou Hanfang Pharmaceutical Company Limited
Contact Person: Ms. Chen Shiqi
Website: https://www.byshanhanfang.com/
Email: Send Email
Contact Number: +8613427652966
Address:No. 8 Wenquan Avenue, Wenquan Town, Conghua District, Guangzhou Guangdong Province, P.R. China
City: Guangzhou
State: Guangdong
Country:China
Release id:45292
The post Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Turn Energy into Profit Gareth Evans’ Newly Released Book Urges Businesses to Build Their Own Energy Infrastructure
United States, 21st May 2026 – Renowned energy strategist and highly experienced business leader Gareth Evans has released his book, Powering Profits: Control Energy Costs, Build Resilience, and Gain a Lasting Competitive Advantage. The new book is an invaluable corporate leadership guide that offers a deep dive into how power systems work and urges businesses to rethink their energy strategy. It provides actionable strategies for business leaders to reduce costs and gain a competitive advantage.
Powering Profits is an insightful executive playbook that provides a strategic framework for CEOs, business leaders, and entrepreneurs to prioritize control, enhance adaptability, and achieve measurable financial outcomes by reimagining their energy strategy. At a time when energy policies and political issues are reshaping the global business landscape, the new book serves as a timely educational resource, highlighting the business risks of relying on aging energy systems that are not only overburdened by rapid business expansion but also vulnerable to extreme weather events and supply chain disruptions. Drawing on years of experience and research across complex energy systems in various industries, the author illuminates a path forward in which self-managed energy can not only protect organizations from disruptions and rising costs but also offer a strategic advantage over time, turning energy into a scalable asset.
Gareth Evans is passionate about helping businesses generate clean, on-site energy that is reliable, affordable, and a powerful asset that drives growth and revenue. Having worked and lived across six continents, he has seen firsthand how centralized energy systems are unreliable and unfair. As the CEO and co-founder of VECKTA, he has dedicated his professional life to empowering businesses to own their power, delivering solutions that improve operational efficiency and create long-term value.
In addition to authoring the Powering Profits Substack, Gareth is the co-host of the Renewable Rides podcast, where he shares his expertise with executives and CEOs across industries. He has worked with globally recognized companies, including Worley, a global leader in reshaping energy solutions.
Gareth Evans is available for interviews.
Title: Powering Profits: Control Energy Costs, Build Resilience, and Gain a Lasting
Competitive Advantage
Author: Gareth Evans
Contact: Michael DeLon
Company: Paperback Expert
Email: press@PaperbackExpert.com
Phone Number: (501) 404-8690
About Gareth Evans: https://veckta.com/our-company/#theteam
Availability: Amazon.com
Book Preview: https://www.amazon.com/dp/B0H1XCVQ31
Media Contact
Organization: Paperback Expert
Contact Person: Michael DeLon
Website: https://paperbackexpert.com/
Email: Send Email
Contact Number: +15014048690
Country:United States
Release id:45325
The post Turn Energy into Profit Gareth Evans’ Newly Released Book Urges Businesses to Build Their Own Energy Infrastructure appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Modern Financial Planning! Brian K. Peterson’s Newly Released Book Redefines How Blended Families Navigate Money
United States, 21st May 2026 – Certified Financial Planner practitioner and wealth management expert Brian K. Peterson has released his book, Blended Family Finances: How to Talk About Money, Plan for the Future, and Build a Life You Love. The new book is a transformative financial planning guide for blended families. It offers a deeply human approach to long-term money management that also accounts for relationships and family values.
Blended Family Finances is a timely guide for today’s evolving family structures, addressing the unique issues blended families face. It offers a flexible roadmap rooted in communication and shared purpose, providing clarity and support to families after loss, divorce, or remarriage. Through real-life stories, the book outlines three key steps: having open conversations about money, creating a shared vision, and using practical strategies for protection. It emphasizes emotional aspects often overlooked in traditional financial planning, filling an important gap.
Brian K. Peterson is a Certified Financial Planner practitioner and a Certified Private Wealth Advisor® with a passion for helping blended families plan for a stable, secure financial future. As a dad in a blended family, his personal experience complements his professional expertise, enabling him to help families achieve their financial goals through meaningful communication and intentional living. Widely known as “The Financial Planner for Blended Families
,” he is the founder of Blended Family Financial.
Over the years, Brian has developed his proprietary framework, the Planning Built for Life® process, which helps couples move beyond traditional planning and navigate money matters with confidence and unity. His new book combines his unique philosophy with practical financial knowledge, empowering families to create a better life.
Brian K. Peterson CFP® is available for interviews.
Title: Blended Family Finances: How to Talk About Money, Plan for the Future,
and Build a Life You Love
Author: Brian K. Peterson CFP®
Contact: Michael DeLon
Company: Paperback Expert
Email: press@PaperbackExpert.com
Phone Number: (501) 404-8690
About Brian K. Peterson: https://www.blendedfamilyfinancial.com/about
Availability: Amazon.com
Book Preview: https://www.amazon.com/dp/B0GX2ZQRK9
Media Contact
Organization: Paperback Expert
Contact Person: Michael DeLon
Website: https://paperbackexpert.com/
Email: Send Email
Contact Number: +15014048690
Country:United States
Release id:45324
The post Modern Financial Planning! Brian K. Peterson’s Newly Released Book Redefines How Blended Families Navigate Money appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Baiyunshan Hanfang Pharmaceutical Releases Technical Progress on Industrial High-Purity Lipid Raw Materials
Turn Energy into Profit Gareth Evans’ Newly Released Book Urges Businesses to Build Their Own Energy Infrastructure
Modern Financial Planning! Brian K. Peterson’s Newly Released Book Redefines How Blended Families Navigate Money
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release3 days ago
Community Rallies Around Tracey Archer Family Following Sudden Loss of Noah Thomas Archer
-
Press Release3 days ago
PortaProfits Releases Transparency Report: 30+ Partner Reviews Now Public
-
Press Release1 week ago
CEMOTO D series Electric Dirt Bike: Redefining Off-Road Adventure with Zero-Emission Power
-
Press Release5 days ago
King VPN Offers 100+ Free VPN Locations for USA Users
-
Press Release5 days ago
Prime VPN: A Fast and Simple VPN App for UK Users with 70+ Free VPN locations
-
Press Release5 days ago
Secure VPN Announces 50+ Free VPN Locations for US Android Users
-
Press Release5 days ago
Readers Favorite announces the review of the Non-Fiction – Memoir book A Past That Lies Before Me by Steve Clark, PhD
-
Press Release5 days ago
Readers Favorite announces the review of the Non-Fiction – Memoir book A Past That Lies Before Me by Steve Clark, PhD